2025 Scrip Asia 100
Latest Updates And Considerations In Asia Pacific
Japan
Collaborations between large pharma companies and digital therapeutics firms have been growing in the last few years. Otsuka and Click’s Rejoyn is the latest step forward.
Breaking Barriers: Japan's PMDA To Open First Global Office, In D.C.
Through a new full-time office in the US capital, Japan's drug regulator aims to provide essential regulatory information to help US bioventures enter the Japanese market at an early stage.
